Gedeon Richter Ltd S/Gdr (GEDSF) Q1 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

So, good morning again and a very warm welcome to Gedeon Richter's first quarter 2026 conference call. My name is Robert Reti, Head of Investor Relations in ESG, the company, and it's my pleasure to welcome two members of the senior leadership team with me today for this call. László Kovács, Chief Financial Officer, and Tomáš Sojak, our Chief Commercial Officer. And the reason why Gabor is not with us, Gabor Orban, our CEO, is that he's on a business trip to Japan meeting our partners in this important country. Before we start the meeting, let me just quickly walk you through the usual technical details. We will be using presentation slides. This presentation is downloadable from our website, getonrichter.com. This is what we published this morning along with our results. The formal presentation will be followed by usual Q&A where you will have an opportunity to ask questions either through the raise your hand functionality of Microsoft Teams or in the chat box. And finally, just to remind you, this poll is recorded and I also want to draw your attention to the usual cautionary statement regarding potential forward-looking statements this presentation may include. And with that, let me hand it over to László, who will present the details of the last three months. Thank you. Thank you. Thank you, Robi. The first quarter of 2026 was eventful and broadly in line with our expectations. The strong momentum continued across our innovative businesses, more notably CNS supported by the sustained outstanding performance of Raylar and by solid revenue contribution from biotech segment. This was partially offset by a softer than planned start of the year in case of women's healthcare, which was largely driven by delivery timing effects and in case of general medicines by multip...